Cedars-Sinai researchers analyzed thousands of social media posts to determine the biggest concerns patients with inflammatory bowel disease (IBD) have about their prescribed treatments.
May 19, 2017
0
1
A University of Manchester test on the mucus lining of the intestine, performed in mice, has found changes in bacteria that could lead to inflammatory bowel disease 12 weeks earlier than previously possible through looking ...
May 15, 2017
0
4
A key gene that helps to explain an underlying cause of incurable bowel disorders such as Crohn's disease has been identified by scientists.
May 15, 2017
0
5
The constitution of an IBD patient's microbiome may help predict whether treatment with a therapeutic antibody will prove fruitful, according to an early-stage study.
May 11, 2017
0
52
An international team of researchers has discovered that a microRNA produced by certain white blood cells can prevent excessive inflammation in the intestine. The study, "Myeloid-derived miR-223 regulates intestinal inflammation ...
May 9, 2017
0
84
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be ...
May 9, 2017
0
1
In patients with colitis, a serious condition affecting the gut, the immune system turns against the body's own microbes, causing inflammation. To combat this inflammation, scientists have focused in on a chemical signal ...
May 9, 2017
0
149
(HealthDay)—A new study finds that people with moderate to severe ulcerative colitis who haven't done well on other treatments may find relief with Xeljanz (tofacitinib), a drug currently used to treat arthritis.
May 3, 2017
0
68
A single transplant of microbes contained in the stool of a healthy donor is a safe and effective way to increase diversity of good bacteria in the guts of patients with ulcerative colitis, according to new research from ...
Apr 27, 2017
1
78
A diet supplemented with soy protein may be an effective adjunct therapy for inflammatory bowel diseases, Penn State researchers reported after completing a study that included mice and cultured human colon cells.
Apr 26, 2017
0
20
